Total Valuation
Imunon has a market cap or net worth of €7.99M. The enterprise value is €10.29.
Market Cap€7.99M
Enterprise Value€10.29
Share Statistics
Imunon has 5,611,403 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,611,403
Owned by Insiders4.88%
Owned by Institutions3.19%
Financial Efficiency
Imunon’s return on equity (ROE) is -2.05 and return on invested capital (ROIC) is -181.53%.
Return on Equity (ROE)-2.05
Return on Assets (ROA)-1.18
Return on Invested Capital (ROIC)-181.53%
Return on Capital Employed (ROCE)-1.91
Revenue Per Employee0.00
Profits Per Employee-724.75K
Employee Count20
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Imunon is ―. Imunon’s PEG ratio is 0.00825.
PE Ratio―
PS Ratio0.00
PB Ratio1.15
Price to Fair Value1.15
Price to FCF-0.57
Price to Operating Cash Flow>-0.01
PEG Ratio0.00825
Income Statement
In the last 12 months, Imunon had revenue of 0.00 and earned -14.49M in profits. Earnings per share was -6.83.
Revenue0.00
Gross Profit0.00
Operating Income-14.65M
Pretax Income-14.50M
Net Income-14.49M
EBITDA-13.80M
Earnings Per Share (EPS)-6.83
Cash Flow
In the last 12 months, operating cash flow was -4.00B and capital expenditures -69.08M, giving a free cash flow of -4.07B billion.
Operating Cash Flow-4.00B
Free Cash Flow-4.07B
Free Cash Flow per Share-725.65
Dividends & Yields
Imunon pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-75.90%
50-Day Moving Average1.43
200-Day Moving Average2.32
Relative Strength Index (RSI)42.77
Average Volume (3m)0.00
Important Dates
Imunon upcoming earnings date is Nov 16, 2026, TBA (Confirmed).
Last Earnings DateAug 11, 2026
Next Earnings DateNov 16, 2026
Ex-Dividend Date―
Financial Position
Imunon as a current ratio of 2.32, with Debt / Equity ratio of 187.29%
Current Ratio2.32
Quick Ratio2.32
Debt to Market Cap0.07
Net Debt to EBITDA0.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Imunon has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Imunon EV to EBITDA ratio is -0.02, with an EV/FCF ratio of -0.02.
EV to Sales0.00
EV to EBITDA-0.02
EV to Free Cash Flow-0.02
EV to Operating Cash Flow-0.02
Balance Sheet
Imunon has €6.86M in cash and marketable securities with €7.85M in debt, giving a net cash position of -€980.91K billion.
Cash & Marketable Securities€6.86M
Total Debt€7.85M
Net Cash-€980.91K
Net Cash Per Share-€0.17
Tangible Book Value Per Share€3.33
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Imunon is €15.17, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€15.17
Price Target Upside1123.49% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast73.74%